ARK Investment Management LLCARK Investment Management LLC

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings222 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TESLA INC

4.8M$1.3B8.4%$213.40+20.66%
19 qtrssince 2018-Q4
Decreased
0

COINBASE GLOBAL INC -CLASS A

12.1M$867.3M5.7%$144.27-50.40%
9 qtrssince 2021-Q2
Increased
64

UIPATH INC

48.3M$800M5.3%$40.21-58.57%
9 qtrssince 2021-Q2
Increased
66

ROKU INC

12M$764.9M5.1%$139.23-54.75%
17 qtrssince 2019-Q2
Decreased
0

BLOCK INC

10.7M$714.1M4.7%$120.54-46.58%
19 qtrssince 2018-Q4
Increased
59

ZOOM COMMUNICATIONS INC

10.5M$710.2M4.7%$209.80-67.78%
11 qtrssince 2020-Q4
Decreased
0
EXASEXASDelisted

EXACT SCIENCES CORP

7.2M$671.9M4.4%$101.30-6.93%
12 qtrssince 2020-Q3
Decreased
0

SHOPIFY INC - CLASS A

8.9M$573.3M3.8%$32.53+95.98%
19 qtrssince 2018-Q4
Decreased
0

UNITY SOFTWARE INC

11.9M$518.2M3.4%$81.92-46.68%
12 qtrssince 2020-Q3
Decreased
0

TELADOC HEALTH INC

20.3M$515.1M3.4%$151.73-83.36%
19 qtrssince 2018-Q4
Decreased
0

DRAFTKINGS INC

18.1M$479.9M3.2%$12.40+111.91%
5 qtrssince 2022-Q2
Decreased
0

TWILIO INC - A

7M$447.8M3.0%$199.60-68.32%
19 qtrssince 2018-Q4
Increased
60

CRISPR THERAPEUTICS AG

7.3M$412M2.7%$76.66-25.62%
19 qtrssince 2018-Q4
Decreased
0

INTELLIA THERAPEUTICS INC

9.5M$388.5M2.6%$36.33+12.57%
19 qtrssince 2018-Q4
Decreased
0

ROBLOX CORP -CLASS A

9.3M$375.5M2.5%$52.25-25.86%
10 qtrssince 2021-Q1
Increased
55

PACIFIC BIOSCIENCES CALIF IN

26.6M$354.2M2.3%$14.12-7.09%
17 qtrssince 2019-Q2
Decreased
0

ROBINHOOD MARKETS INC - A

31.9M$318.6M2.1%$22.70-56.07%
8 qtrssince 2021-Q3
Increased
53

Ginkgo Bioworks Holdings, Inc.

169.7M$315.7M2.1%

BEAM THERAPEUTICS INC

8.4M$267.7M1.8%$79.64-60.06%
11 qtrssince 2020-Q4
Decreased
0

PAGERDUTY INC

10.4M$233.3M1.5%$28.34-22.30%
14 qtrssince 2020-Q1
Increased
51
$15.1B
AUM
222
Positions
Q2 2023
Filing
Rating · 3.5
Quarterly Portfolio Change
-28%Q1'22$24B-29%Q2'22$16.9B-15%Q3'22$14.3B-20%Q4'22$11.5B+26%Q1'23$14.6B+4%Q2'23$15.1B
Activity profile
$ moved · Q2'23
New9%Increased33%Decreased57%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 years
<1Q1%1-4Q3%1-2Y14%2Y+82%

ARK Investment Management LLC manages $15.1B across 222 positions as of Q2 2023. Top holdings: TSLA (8.4%), COIN (5.7%), PATH (5.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q2 2023 Summary

Active quarter - 8 new positions, 7 exits, 77 increased. Top move: PATH (INCREASED, conviction 66). Portfolio: $15.1B across 222 positions.

Top holdings by portfolio weight

Total AUM$15B
TSLA8.39%
COIN5.74%
PATH5.30%
ROKU5.06%
XYZ4.73%
ZM4.70%
EXAS4.45%
SHOP3.80%
U3.43%
TDOC3.41%
Other3.18%

Portfolio allocation by GICS sector

Sectors9
Technology33.28%
Healthcare29.50%
Consumer Cyclical12.70%
Communication Services9.37%
Financial Services8.34%
Unknown3.54%
Industrials3.24%
Basic Materials0.02%
Consumer Defensive0.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record59
Conviction44
Concentration59
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
GOOGGOOGALPHABET INC-CL C
Q3 2024 Q2 2026+915,979 shares+$345.3M
6Q
AVAVAVAVAEROVIRONMENT INC
Q1 2025 Q2 2026+343,875 shares+$59.7M
6Q
ISRGISRGINTUITIVE SURGICAL INC
Q1 2025 Q2 2026+50,925 shares+$17.8M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used